Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

Semaglutide, popularly known as Ozempic or Wegovy, has become a celeb-approved weight-loss drug. However, the effects are not ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...

A combination treatment of semaglutide, trevogrumad and garetosmab causes fat loss and muscle growth in primate trials. Full ...

Ozempic, which was introduced into the UK in January 2019, having previously been approved in the US in 2017, is an ...

FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...

A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...

Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...